Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
4.430
+0.635 (16.73%)
At close: May 13, 2025, 4:00 PM
4.470
+0.040 (0.91%)
Pre-market: May 14, 2025, 8:00 AM EDT
Omeros Employees
Omeros had 202 employees as of December 31, 2024. The number of employees increased by 4 or 2.02% compared to the previous year.
Employees
202
Change (1Y)
4
Growth (1Y)
2.02%
Revenue / Employee
n/a
Profits / Employee
-$776,312
Market Cap
257.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OMER News
- 1 day ago - Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025 - Business Wire
- 1 day ago - Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - Business Wire
- 7 days ago - FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date - Business Wire
- 4 weeks ago - Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight - Benzinga
- 4 weeks ago - Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical Program - Business Wire
- 5 weeks ago - Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases - Business Wire
- 6 weeks ago - Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results - Business Wire